Tenderwize
Back to tender search

Open House Originale Rabattverträge 2024-08 - Fluticason/Vilanterol

Techniker Krankenkasse·Hamburg, Germany·Deadline Sep 30, 2026 · 43 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2024-08 - Fluticason/Vilanterol (Wirkstoffkombination)

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

50 / 100

Complexity

20 / 100

Risk factors

No estimated value or volume is provided. The financial potential of the contract is unknown, complicating bid/no-bid d...

The contract ends automatically on patent expiry. If the patent expires early, the contract may be shorter than expecte...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Sep 2026
  • Conclusion of discount contracts for the active ingredient combination Fluticason/Vilanterol
  • Contracts with uniform conditions, no individual negotiations
Show full summary

Open House procedure by Techniker Krankenkasse (TK) and other German health insurers to conclude discount contracts (Rabattverträge) for the active ingredient combination Fluticason/Vilanterol. The procedure is non-competitive: any eligible pharmaceutical entrepreneur can join at any time during the contract period (until 30 Sept 2026). No estimated value, no award criteria (all accepted). Eligibility focuses on being a pharmaceutical entrepreneur with proper marketing authorization. The notice clarifies this is not a public procurement subject to EU directives.

Risks

No estimated value or volume is provided. The financial potential of the contract is unknown, complicating bid/no-bid d...

The contract ends automatically on patent expiry. If the patent expires early, the contract may be shorter than expecte...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur as per § 4 Abs. 18 AMG regarding the offered medicines
  • Must have a valid marketing authorization for the product in Germany/EU/EEA
  • No convictions for certain criminal or economic offenses (last 5 years for §123 GWB, last 3 years for §124 GWB)

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria; all eligible participants are accepted.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open House Originale Rabattverträge 2024-08 - Fluticason/Vilanterol

Discount contracts for Fluticason/Vilanterol combination. Contract duration max 24 months from 01 Oct 2024, ending 30 Sept 2026. Joining possible anytime during the period. No exclusivity.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Sep 2024 - Sep 2026

Category

Pharmaceutical products

Award Criteria

No award criteria; all eligible participants are accepted.

Deadline

Deadline Sep 30, 2026

Procurement Details

Publication date
30 Jul 2024
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
461715-2024

Documents (1)

Similar tenders